向治疗,免疫疗法,小分子和类药物作为新兴的黑色素瘤免疫调节剂
Jingwen Zhang1, Anthony M Joshua2, Yue Li1
1Vascular Biology and Translational Research, Department of Pathology, School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.
Cancer letters
|January 28, 2024
概括
治疗晚期黑色素瘤 (一种致命的皮肤癌) 的进展包括免疫疗法和向疗法. 新的治疗方法,如激酶抑制剂和免疫检查点抑制剂,为晚期黑色素瘤患者提供了改善的临床管理.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 初级皮肤黑色素瘤是一种高度致命的皮肤瘤,发病率越来越高.
- 近年来,在治疗晚期黑色素瘤方面取得了重大进展.
- 随着新型治疗策略的出现,治疗范式发生了变化.
研究的目的:
- 总结最近在晚期黑色素瘤的临床管理方面的进展.
- 提供新兴免疫调节剂和向治疗的概述.
- 突出免疫疗法和向治疗对黑色素瘤治疗的影响.
主要方法:
- 关于高级黑色素瘤治疗的当前文献的综述.
- 免疫疗法的总结,包括免疫检查点抑制剂和采用免疫疗法.
- 讨论针对性疗法,如蛋白激酶抑制剂和小分子.
主要成果:
- 免疫疗法和向疗法彻底改变了黑色素瘤的治疗方法.
- 组合疗法在治疗晚期疾病方面表现有前途.
- 新兴的药物,如类药物,代表了免疫调节的新途径.
结论:
- 在治疗晚期黑色素瘤方面取得了重大进展.
- 免疫疗法和向治疗的整合改变了患者的治疗结果.
- 对新型免疫调节剂的持续研究有望进一步改善治疗方法.
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917


